Immunotherapy Approaches in Hepatocellular Carcinoma – OncLive
OncLive |
Immunotherapy Approaches in Hepatocellular Carcinoma
OncLive Josep Llovet, MD: Immunotherapy has been a change-maker in the management of oncology. It is a natural revolution and has changed the management of several solid tumors. Now, nivolumab is the first checkpoint inhibitor thoroughly tested in HCC and has … |
